News
The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the ...
2d
Stockhead on MSNIsland fast tracks portfolio expansion with acquisition of Galidesivir for ‘high-priority threat’ virusesIsland will now focus on using the FDA’s animal rule to advance the Galidesivir program towards a new drug application (NDA), ...
The US Department of Health and Human Services is weighing whether to fund new Marburg and Sudan Ebola virus vaccines even as Secretary Robert F. Kennedy Jr. overhauls the US immunization landscape, ...
By law, the withdrawal cannot take full effect until early 2026, due to a required one-year notice period. But the order also instructed an immediate halt to US contributions and a phased pullout of ...
The number of measles cases in the U.S. has reached a 33-year record high, years after it was officially eliminated in the ...
A new Covid-19 variant, officially known as NB.1.8.1 and nicknamed Nimbus, is now the most common strain in the US, according ...
Falling vaccination rates could lead to the return of previously eliminated diseases, and many more people will be at risk of ...
The filoviruses Ebola and Marburg use several different and effective mechanisms to both evade and battle the immune system. This Review explores recent findings in the filovirus–host-defence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results